➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Moodys
Express Scripts
Mallinckrodt
Medtronic

Last Updated: October 22, 2020

DrugPatentWatch Database Preview

Details for Patent: 10,040,872

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,040,872 protect, and when does it expire?

Patent 10,040,872 protects EVOMELA and is included in one NDA.

This patent has twenty-five patent family members in seventeen countries.

Summary for Patent: 10,040,872
Title:Alkylated cyclodextrin compositions and processes for preparing and using the same
Abstract: The present invention related to low-chloride alkylated cyclodextrin compositions, along with processes for preparing and using the same. The processes of the present invention provide alkylated cyclodextrins with low levels of drug-degrading agents and chloride.
Inventor(s): Antle; Vincent D. (Olathe, KS), Lopes; lvaro (Loures, PT), Monteiro; Daniel (Loures, PT)
Assignee: CyDex Pharmaceuticals, Inc. (San Diego, CA)
Application Number:14/437,439
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,040,872
Patent Claim Types:
see list of patent claims
Use; Composition; Process;

Drugs Protected by US Patent 10,040,872

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acrotech EVOMELA melphalan hydrochloride POWDER;INTRAVENOUS 207155-001 Mar 10, 2016 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Merck
McKesson
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.